Hugh McMillan

Professor, Department of Pediatrics, University of Ottawa

Pediatric Neurologist and Neuromuscular specialist at the Children’s Hospital of Eastern Ontario

Email Hugh

Dr. McMillan is a Pediatric Neurologist with specialization in Clinical Neurophysiology and Neuromuscular medicine at the Children’s Hospital of Eastern Ontario. He is a Professor in the Department of Pediatrics, Faculty of Medicine at the University of Ottawa.  He holds a Clinical Research Chair (Level 2) at the University of Ottawa and is a Clinical Investigator at the CHEO Research Institute

He has been an author of over 125 publications in peer-review journals and was a co-editor of a Pediatric Electromyography textbook.  He is also a leader in clinical and translational research in pediatric neurology & neuromuscular medicine.

Dr. McMillan completed a Neuromuscular and Neurophysiology Fellowship at Boston Children’s Hospital, Harvard University and the Lahey Clinic, Tufts University; a Pediatric Neurology Residency at the Children’s Hospital of Eastern Ontario, University of Ottawa and a Pediatric Residency at McMaster Children’s Hospital, McMaster University.

Dr. Hugh McMillan profile picture.

Read more about Hugh

Academic web profile
ORCiD profile

Recent publications

Eisenkölbl, A, Burgess, T, Howley, H, Parkes, E, Comeau, G, Berard, JA et al.. Music and movement intervention for brain-heart disease in children with myotonic dystrophy type 1 (DM1): a convergent mixed-methods feasibility study protocol. Pilot Feasibility Stud. 2026.12 (1) PMID:42972444

Ward, LM, Jackowski, S, Dang, UJ, B Comm, MS, Jaremko, JL, Koujok, K et al.. Muscle function, linear growth, and bone health during 30 months of vamorolone, prednisone, and deflazacort treatment for Duchenne muscular dystrophy: a comparative study. J Bone Miner Res. 2026. PMID:42954866

Smith, IC, Grant, A, Lessard, LER, Osman, H, Oelbrandt, F, Lochmüller, H et al.. Socioeconomic costs and health-related quality of life associated with oculopharyngeal muscular dystrophy. Front Public Health. 2026.14 1918801 PMID:42935765

McMillan, HJ, Osman, H, Kernohan, K, Lacaria, M, Hume, SL, Muranyi, A et al.. Nationwide Implementation of Newborn Screening for Spinal Muscular Atrophy in Canada. Neurol Genet. 2026.12 (6)e200451 PMID:42899123

Rutter, MM, Crane, JL, Babalola, F, Benjamin, RW, Lam, C, McAdam, L et al.. Managing growth and puberty concerns in individuals with Duchenne muscular dystrophy: Updated guidance and future directions. J Neuromuscul Dis. 2026. 22143602261486896 PMID:42857968

Sbrocchi, AM, Ahmet, A, Kinnett, K, Lautatzis, ME, McMillan, HJ, Apkon, S et al.. A structured approach to address variability in the global management of adrenal insufficiency in Duchenne muscular dystrophy: the 2025 PJ Nicholoff steroid protocol. Front Neurol. 2026.17 1926817 PMID:42787106

Weber, DR, Ahmet, A, Kinnett, K, Lautatzis, ME, McMillan, HJ, Apkon, S et al.. Adrenal insufficiency in individuals with Duchenne muscular dystrophy treated with glucocorticoids: Insights from the past, current challenges, and future directions. J Neuromuscul Dis. 2026. 22143602261485046 PMID:42770351

Orbach, R, Gil Garzon, MR, Büning, H, Bönnemann, C, Muntoni, F, 289th ENMC Workshop participants et al.. 289th ENMC international workshop: assessing and managing emerging AAV related toxicities after gene therapy for neuromuscular disorders, 26 - 28 September 2025, Hoofddorp, The Netherlands. Neuromuscul Disord. 2026.67 107371 PMID:42668237

Halloun, R, Jackowski, S, Scharke, M, Dang, UJ, Alshammri, F, Ma, J et al.. Total body and appendicular lean mass by dual-energy X-ray absorptiometry are highly associated with muscle function and bone mineral density in Becker muscular dystrophy. J Neuromuscul Dis. 2026. 22143602261476364 PMID:42663311

Sutton, ER, Beauvais, A, Yaworski, R, McMillan, HJ, Kothary, R. Maternal-Fetal Administration of Risdiplam Partially Rescues the SMNΔ7 Mouse Model of Spinal Muscular Atrophy. Ann Neurol. 2026.100 (3)584-599 PMID:42458739

See more on PubMed